183 related articles for article (PubMed ID: 19506525)
41. Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension.
Ivanova OV; Fomicheva OA; Sergakova LM; Chernova NA; Rogoza AN; Karpov YA
J Int Med Res; 2005; 33 Suppl 1():21A-29A. PubMed ID: 16222897
[TBL] [Abstract][Full Text] [Related]
42. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
[TBL] [Abstract][Full Text] [Related]
43. A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
Galzerano D; Di Michele S; Paolisso G; Tuccillo B; Lama D; Carbotta S; Cittadini A; Tedesco MA; Gaudio C
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):496-503. PubMed ID: 22546623
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
Tsutsui H; Matsushima S; Kinugawa S; Ide T; Inoue N; Ohta Y; Yokota T; Hamaguchi S; Sunagawa K
Hypertens Res; 2007 May; 30(5):439-49. PubMed ID: 17587756
[TBL] [Abstract][Full Text] [Related]
45. Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess.
Susic D; Frohlich ED
J Am Soc Hypertens; 2014 May; 8(5):297-302. PubMed ID: 24726099
[TBL] [Abstract][Full Text] [Related]
46. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
47. [Hypotensive effects of telmisartan on blood pressure during rest and exercise in patients with mild and moderate arterial hypertension].
Sakalyte G; Kavoliūniene A; Vainoras A; Jurkevicius R
Medicina (Kaunas); 2002; 38(9):901-9. PubMed ID: 12474774
[TBL] [Abstract][Full Text] [Related]
48. Pre-clinical and clinical experience of telmisartan in cardiac remodelling.
Verdecchia P
J Int Med Res; 2005; 33 Suppl 1():12A-20A. PubMed ID: 16222896
[TBL] [Abstract][Full Text] [Related]
49. Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients.
Hasegawa H; Takano H; Narumi H; Ohtsuka M; Mizuguchi T; Namiki T; Kobayashi Y; Komuro I
Hypertens Res; 2011 Nov; 34(11):1179-84. PubMed ID: 21796128
[TBL] [Abstract][Full Text] [Related]
50. Left ventricular circumferential function in patients with essential hypertension.
Przewlocka-Kosmala M; Kosmala W; Mazurek W
J Hum Hypertens; 2006 Sep; 20(9):666-71. PubMed ID: 16738687
[TBL] [Abstract][Full Text] [Related]
51. Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction.
Fonseca CG; Dissanayake AM; Doughty RN; Whalley GA; Gamble GD; Cowan BR; Occleshaw CJ; Young AA
Am J Cardiol; 2004 Dec; 94(11):1391-5. PubMed ID: 15566909
[TBL] [Abstract][Full Text] [Related]
52. Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertension.
Syrbe U; Moebes A; Scholze J; Swidsinski A; Dörffel Y
Hypertens Res; 2007 Jun; 30(6):521-8. PubMed ID: 17664855
[TBL] [Abstract][Full Text] [Related]
53. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.
Cadeddu C; Piras A; Mantovani G; Deidda M; Dessì M; Madeddu C; Massa E; Mercuro G
Am Heart J; 2010 Sep; 160(3):487.e1-7. PubMed ID: 20826257
[TBL] [Abstract][Full Text] [Related]
54. Contribution of the pericardium to left ventricular torsion and regional myocardial function in patients with total absence of the left pericardium.
Tanaka H; Oishi Y; Mizuguchi Y; Miyoshi H; Ishimoto T; Nagase N; Yamada H; Oki T
J Am Soc Echocardiogr; 2008 Mar; 21(3):268-74. PubMed ID: 17628423
[TBL] [Abstract][Full Text] [Related]
55. Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously hypertensive rats.
Susic D; Fares H; Frohlich ED
J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):126-32. PubMed ID: 22927675
[TBL] [Abstract][Full Text] [Related]
56. Abnormal right ventricular mechanics in early systemic hypertension: a two-dimensional strain imaging study.
Pedrinelli R; Canale ML; Giannini C; Talini E; Dell'Omo G; Di Bello V
Eur J Echocardiogr; 2010 Oct; 11(9):738-42. PubMed ID: 20472915
[TBL] [Abstract][Full Text] [Related]
57. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension.
Ariff B; Zambanini A; Vamadeva S; Barratt D; Xu Y; Sever P; Stanton A; Hughes A; Thom S
Stroke; 2006 Sep; 37(9):2381-4. PubMed ID: 16888272
[TBL] [Abstract][Full Text] [Related]
58. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure.
Alchanatis M; Paradellis G; Pini H; Tourkohoriti G; Jordanoglou J
Respiration; 2000; 67(4):367-71. PubMed ID: 10940788
[TBL] [Abstract][Full Text] [Related]
59. Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.
Yokota T; Osanai T; Hanada K; Kushibiki M; Abe N; Oikawa K; Tomita H; Higuma T; Yokoyama J; Hanada H; Okumura K
Heart Vessels; 2010 Nov; 25(6):460-8. PubMed ID: 20922537
[TBL] [Abstract][Full Text] [Related]
60. Alteration in left ventricular strains and torsional mechanics after ultralong duration exercise in athletes.
Nottin S; Doucende G; Schuster I; Tanguy S; Dauzat M; Obert P
Circ Cardiovasc Imaging; 2009 Jul; 2(4):323-30. PubMed ID: 19808613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
